Immune response and homeostasis mechanism following administration of BBIBP-CorV SARS-CoV-2 inactivated vaccine

Yin, JH; Zhao, YZ; Huang, FBQ; Yang, YK; Huang, YL; Zhuang, ZK; Wang, YX; Wang, ZF; Lin, XM; Zheng, YH; Zhou, WW; Wang, S; Xu, ZQ; Ye, BW; Guo, YX; Lei, WW; Li, L; Tian, JM; Gan, JX; Wang, H; Wang, W; Ma, PY; Liu, C; Wei, XY; Shi, XY; Wang, ZF; Wang, Y; Liu, Y; Yang, MM; Yuan, Y; Song, YM; Ma, W; Huang, ZL; Liu, Y; Huang, YT; Lu, HR; Liu, PP; Liang, H; Hou, Y; Xu, X; Liu, LQ; Zhang, YT; Wu, GZ; Gao, GF; Jin, X; Liu, CY; Yang, XM; Liu, WJ

Jin, X; Liu, CY (通讯作者),BGI Shenzhen, Shenzhen 518103, Peoples R China.;Wu, GZ; Gao, GF; Liu, WJ (通讯作者),Chinese Ctr Dis Control & Prevent China CDC, Natl Inst Viral Dis Control & Prevent, NHC Key Lab Biosafety, Beijing 100052, Peoples R China.;Gao, GF; Liu, WJ (通讯作者),Chinese Acad Med Sci, Res Unit Adapt Evolut & Control Emerging Viruses, Beijing 102206, Peoples R China.;Wu, GZ; Gao, GF; Liu, WJ (通讯作者),Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan 430071, Peoples R China.;Wu, GZ; Gao, GF; Liu, WJ (通讯作者),South China Univ Technol, Sch Biol & Biol Engn, Guangzhou 510006, Peoples R China.;Zhang, YT; Yang, XM (通讯作者),China Natl Biotec Grp Co Ltd, Beijing 100029, Peoples R China.;Liu, CY (通讯作者),Univ Chinese Acad Sci, Coll Life Sci, Beijing 100049, Peoples R China.;Yang, XM (通讯作者),South China Agr Univ, Guangdong Prov Key Lab Human Dis Genom, Shenzhen Key Lab Genom, Guangzhou 510642, Peoples R China.;Jin, X (通讯作者),Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou 325035, Peoples R China.;Liu, CY (通讯作者),BGI Hangzhou, Hangzhou 310012, Peoples R China.;Gao, GF (通讯作者),Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.;Jin, X (通讯作者),South China Univ Technol, Sch Med, Guangzhou 510006, Peoples R China.;Jin, X (通讯作者),BGI Shenzhen, Shenzhen Key Lab Genom, Guangdong Prov Key Lab Human Dis Genom, Shenzhen 518083, Peoples R China.;Yang, XM (通讯作者),Wuhan Inst Biol Prod Co Ltd, Natl Engn Technol Res Ctr Combined Vaccines, Wuhan 430207, Peoples R China.

INNOVATION, 2023; 4 (1):

Abstract

The BBIBP-CorV severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) inactivated vaccine has been authorized for emergency use and widely distri......

Full Text Link